Innovation & Research at the Bass Center

Because childhood cancers are so rare, most young patients are referred here because of our expertise and experience. At Lucile Packard Children's Hospital Stanford, we have a pediatric cancer treatment and research program that’s known globally for the treatment of non-Hodgkin's lymphoma, Hodgkin's disease, leukemia and brain tumors.

Our physicians hold leadership roles in the national clinical research consortium Children's Oncology Group (COG). This group — representing the merger of four national pediatric cancer research groups — designs and evaluates cancer therapies through large clinical trials. We also conduct a number of trials of experimental drugs that can offer new treatment options for patients who have failed other therapies.

Clinical Trial: Diamond Blackfan Anemia Patient Study

Diamond Blackfan anemia (DBA) is a rare genetic blood disorder that is usually diagnosed in children during their first year of life. Steroids are used as a common treatment method, but many patients will also require ongoing blood transfusions, for which there are several side-effects.

For patients requiring blood transfusions, the amino acid leucine has shown in early studies to be a successful treatment option without side effects and has led to a nationwide pilot to determine if it is a safe and effective treatment for patients with DBA. The basic eligibility requirements are that the patient has a diagnosis of DBA, is over the age of two and transfusion dependent.

Lucile Packard Children’s Hospital Stanford is the only location in the Western U.S. currently participating in this study.

Bertil Glader, MD, PhD
Professor, Pediatric Hematology/Oncology
E-mail: bglader@stanford.edu

Anupama Narla, MD
Assistant Professor, Pediatric Hematology/Oncology
E-mail: anunarla@stanford.edu

For more information and to enroll a patient in the study, call (650) 723-5535 or e-mail one of our faculty members.

Recent Acknowledgements & Grants

For more information about our research and clinical trials, call (650) 497-8953.